Disposition of 127 shares by Hanjoon Kim of Standard Biotools at 1.27 subject to Rule 16b-3
LAB Stock | USD 1.27 0.02 1.55% |
About 54% of Standard Biotools' investor base is interested to short. The analysis of overall sentiment of trading Standard Biotools stock suggests that many investors are impartial at this time. The current market sentiment, together with Standard Biotools' historical and current headlines, can help investors time the market. In addition, many technical investors use Standard Biotools stock news signals to limit their universe of possible portfolio assets.
Filed transaction by Standard Biotools Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
Standard Biotools' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Standard Biotools' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Standard Biotools Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Standard Biotools can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Standard Biotools Historical Investor Sentiment
Investor biases related to Standard Biotools' public news can be used to forecast risks associated with an investment in Standard. The trend in average sentiment can be used to explain how an investor holding Standard can time the market purely based on public headlines and social activities around Standard Biotools. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Standard Biotools' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Standard Biotools and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Standard Biotools news discussions. The higher the estimate score, the more favorable the investor's outlook on Standard Biotools.
Standard Biotools Fundamental Analysis
We analyze Standard Biotools' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Standard Biotools using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Standard Biotools based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Standard Biotools is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Standard Biotools Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Standard Biotools stock to make a market-neutral strategy. Peer analysis of Standard Biotools could also be used in its relative valuation, which is a method of valuing Standard Biotools by comparing valuation metrics with similar companies.
Peers
Standard Biotools Related Equities
INBX | Inhibrx Biosciences, | 1.78 | ||||
AVNS | Avanos Medical | 0.26 | ||||
VREX | Varex Imaging | 0.43 | ||||
SNDA | Sonida Senior | 0.87 | ||||
CBLL | CeriBell, | 2.16 | ||||
LXRX | Lexicon Pharmaceuticals | 3.40 | ||||
SLDB | Solid Biosciences | 4.55 | ||||
GOSS | Gossamer Bio | 5.19 | ||||
PACB | Pacific Biosciences | 6.82 | ||||
CGEM | Cullinan Oncology | 10.07 |
Complementary Tools for Standard Stock analysis
When running Standard Biotools' price analysis, check to measure Standard Biotools' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Biotools is operating at the current time. Most of Standard Biotools' value examination focuses on studying past and present price action to predict the probability of Standard Biotools' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Biotools' price. Additionally, you may evaluate how the addition of Standard Biotools to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |